vasopressin V2 agonist (Otsuka)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namevasopressin V2 agonist (Otsuka)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVasopressin V2 receptor agonists
TargetsVasopressin V2 receptor
Therapy Area/IndicationsHyponatremiaUrinary IncontinenceNephrotic Syndrome +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOtsuka Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOtsuka Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsHyponatremiaUrinary IncontinenceNephrotic Syndrome +[4] 

Other Information

ATC CodeN/A
Related LinksN/A